RQx Pharmaceuticals Company Profile
RQx Pharmaceuticals, founded in 2010 and headquartered in San Diego, CA, is a small drug discovery company with 6 employees specializing in broad spectrum small molecule antibiotics targeting life-threatening, multi drug-resistant Gram-negative bacterial infections, was acquired by Genentech in a $111 million deal in 2013, holds 75 patent documents including active macrocyclic antibiotic patents filed in 2017, and had early investments from Avalon Ventures and Correlation Ventures.
Overview
RQx Pharmaceuticals is a developer of broad spectrum small molecule antibiotics, focusing on treatments for life-threatening infections, including those caused by multi drug-resistant Gram-negative bacteria.
- Year Founded: 2010
- Status: Acquired/Merged
- Employees: 6
- Latest Deal Type: M&A
- Latest Deal Amount: $111M
- Corporate Office: 11099 North Torrey Pines Road, San Diego, CA 92121, United States
- Primary Industry: Drug Discovery
- Acquirer: Genentech
Valuation & Funding
- Merger/Acquisition: 12-Feb-2013, $111M, Completed, Startup stage
- Early Stage VC (Series A): 16-Feb-2011, Completed, Startup stage
Cap Table
- Series A
- (Details not disclosed)
Patents
- Total Documents (Applications and Grants): 75
- Total Patent Families: (Not specified)
- Granted: 38
- Pending: 4
- Expiring in next 12 months: (Not specified)
Recent Patent Activity
- ES-2979245-T3: Broad spectrum macrocyclic antibiotics, Active, First Filing Date: 15-Feb-2017
- AU-2018222093-A1: Macrocyclic broad spectrum antibiotics, Active, First Filing Date: 15-Feb-2017
- AU-2018222093-B2: Macrocyclic broad spectrum antibiotics, Active, First Filing Date: 15-Feb-2017
- AU-2022201724-A1: Macrocyclic broad spectrum antibiotics, Active, First Filing Date: 15-Feb-2017
- AU-2022201724-B2: Macrocyclic broad spectrum antibiotics, Active, First Filing Date: 15-Feb-2017, Technology: A61P31/04
Former Investors
- Avalon Ventures (Venture Capital, Minority holding)
- Correlation Ventures (Venture Capital, Minority holding)
FAQs
When was RQx Pharmaceuticals founded?
RQx Pharmaceuticals was founded in 2010.
Where is RQx Pharmaceuticals headquartered?
RQx Pharmaceuticals is headquartered in San Diego, CA.
What is the size of RQx Pharmaceuticals?
RQx Pharmaceuticals has 6 total employees.
What industry is RQx Pharmaceuticals in?
RQx Pharmaceuticals’s primary industry is Drug Discovery.
Is RQx Pharmaceuticals a private or public company?
RQx Pharmaceuticals is a private company.
What is the current valuation of RQx Pharmaceuticals?
The current valuation of RQx Pharmaceuticals is not specified.
What is RQx Pharmaceuticals’s current revenue?
The current revenue for RQx Pharmaceuticals is not specified.
How much funding has RQx Pharmaceuticals raised over time?
RQx Pharmaceuticals has raised $1.19M.
Who are RQx Pharmaceuticals’s investors?
Avalon Ventures and Correlation Ventures have invested in RQx Pharmaceuticals.
When was RQx Pharmaceuticals acquired?
RQx Pharmaceuticals was acquired on 12-Feb-2013.
Who acquired RQx Pharmaceuticals?
RQx Pharmaceuticals was acquired by Genentech.